2008China Medical HeraldRequires access

Clinic study on effect of acanthopanax injection and benazepri1 in treating the early stage of diabetic nephropathy

LI Guan-he

Open publisher page 0 citations

Abstract

Objective: To investigate the combined effects of acanthopanax injection and benazepri1 treatment on the early stage of diabetic nephropathy. Methods:60 patients with the early stage of diabetic nephropathy were divided into 2 groups:combined treatment group and benazepri1 group. The patients were treated with acanthopanax injection and benazepri1 or benazepril. Then detect the levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine before and after the treatment.Results:The levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine of the patients were obviously decreased in 2 groups. The data of combined treatment group was better than the benazepri1 group.Conclusion:The combined treatment of acanthopanax injection and benazepri1 are effect on the early stage of diabetic nephropathy.

About this research paper

What this paper is about

Objective: To investigate the combined effects of acanthopanax injection and benazepri1 treatment on the early stage of diabetic nephropathy. Methods:60 patients with the early stage of diabetic nephropathy were divided into 2 groups:combined treatment group and benazepri1 group. The patients were treated with acanthopanax injection and benazepri1 or benazepril. Then detect the levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine before and after the treatment.Results:The levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine of the patients were obviously decreased in 2 groups. The data of combined treatment group was better than the benazepri1 group.Conclusion:The combined treatment of acanthopanax injection and benazepri1 are effect on the early stage of diabetic nephropathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the combined effects of acanthopanax injection and benazepri1 treatment on the early stage of diabetic nephropathy. Methods:60 patients with the early stage of diabetic nephropathy were divided into 2 groups:combined treatment group and benazepri1 group. The patients were treated with acanthopanax injection and benazepri1 or benazepril. Then detect the levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine before and after the treatment.Results:The levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine of the patients were obviously decreased in 2 groups. The data of combined treatment group was better than the benazepri1 group.Conclusion:The combined treatment of acanthopanax injection and benazepri1 are effect on the early stage of diabetic nephropathy.

Key concepts: Medicine, Diabetic nephropathy, Benazepril, Creatinine, Blood urea nitrogen, Excretion, Blood pressure, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinic study on effect of acanthopanax injection and benazepri1 in treating the early stage of diabetic nephropathy — Research Paper | ScholarLens